Assessment of Chimpanzee Adenovirus Serotype 63 Neutralizing Antibodies Prior to Evaluation of a Candidate Malaria Vaccine Regimen Based on Viral Vectors

Prior to a chimpanzee adenovirus-based (ChAd63) malarial vaccine trial, sera were collected to assess ChAd63-specific neutralizing antibody titers in Banfora (Burkina Faso). The low neutralizing antibody titers reported in both adults and children (median titers, 139.1 and 35.0, respectively) are en...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nébié, Issa, Edwards, Nick J., Tiono, Alfred B., Ewer, Katie J., Sanou, Guillaume S., Soulama, Issiaka, Sanon, Souleymane, Diarra, Amidou, Yaro, Jean Baptiste, Kangoye, David, Imoukhuede, Egeruan B., Hill, Adrian V. S., Sirima, Sodiomon B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Vaccines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4054245/
https://ncbi.nlm.nih.gov/pubmed/24739980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00723-13
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados